Position Paper – Revision of the Pharmaceutical legislation

Medicines for Europe is committed to improving public health through improved access, availability and affordability of medicines, in line with the pharmaceutical strategy for Europe.

Open

Parliament compromise on pharmaceutical legislation… 19 March 2024 Today, the Members of the Parliament’s health committee (ENVI) adopted…
OPEN LETTER: Members of the European Parliament and EU 27… 8 November 2023 Medicines for Europe, the European association representing generic, biosimilar and…
Future of pharmaceutical policy rests on secure supply of… 3 May 2023 The recently published EU pharmaceutical revision aims to improve medicines…
Impact of extending the duration of regulatory data… 14 February 2024 In the context of the new EU pharmaceutical legislation, this…

Related Posts